Latest & greatest articles for dementia

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on dementia or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on dementia and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for dementia

61. Identifying Performance Measures, Indicators and Targets to Monitor and Evaluate Dementia Strategies

Identifying Performance Measures, Indicators and Targets to Monitor and Evaluate Dementia Strategies The image part with relationship ID rId9 was not found in the file. Rapid Synthesis Identifying Performance Measures, Indicators and Targets to Monitor and Evaluate Dementia Strategies 6 April 2018 McMaster Health Forum 1 Evidence >> Insight >> Action Rapid Synthesis: Identifying Performance Measures, Indicators and Targets to Monitor and Evaluate Dementia Strategies Three-day response 6 April (...) 2018 Identifying Performance Measures, Indicators and Targets to Monitor and Evaluate Dementia Strategies 2 Evidence >> Insight >> Action McMaster Health Forum The McMaster Health Forum’s goal is to generate action on the pressing health-system issues of our time, based on the best available research evidence and systematically elicited citizen values and stakeholder insights. We aim to strengthen health systems – locally, nationally, and internationally – and get the right programs, services

2018 McMaster Health Forum

62. Anticholinergic drugs and risk of dementia: case-control study. (PubMed)

Anticholinergic drugs and risk of dementia: case-control study. OBJECTIVES: To estimate the association between the duration and level of exposure to different classes of anticholinergic drugs and subsequent incident dementia. DESIGN: Case-control study. SETTING: General practices in the UK contributing to the Clinical Practice Research Datalink. PARTICIPANTS: 40 770 patients aged 65-99 with a diagnosis of dementia between April 2006 and July 2015, and 283 933 controls without dementia (...) . INTERVENTIONS: Daily defined doses of anticholinergic drugs coded using the Anticholinergic Cognitive Burden (ACB) scale, in total and grouped by subclass, prescribed 4-20 years before a diagnosis of dementia. MAIN OUTCOME MEASURES: Odds ratios for incident dementia, adjusted for a range of demographic and health related covariates. RESULTS: 14 453 (35%) cases and 86 403 (30%) controls were prescribed at least one anticholinergic drug with an ACB score of 3 (definite anticholinergic activity) during

Full Text available with Trip Pro

2018 BMJ

63. Person-centred care improves quality of life for care home residents with dementia

Person-centred care improves quality of life for care home residents with dementia NIHR DC | Signal - Person-centred care improves quality of life for care home residents with dementia Dissemination Centre Discover Portal NIHR DC Discover Person-centred care improves quality of life for care home residents with dementia Published on 20 March 2018 A person-centred care intervention for people with dementia living in care homes improved their quality of life, reduced agitation and improved (...) antipsychotic use, as this was low to start with, which is in line with policy to limit use. It supports the feasibility of the intervention, but there is a need to understand which components are most effective and could be implemented on a wide scale with sustainable effects. Share your views on the research. Why was this study needed? Over 400,000 older people currently live in care homes in the UK. This includes over a third of the UK population with dementia. Many people with dementia have complex care

2018 NIHR Dissemination Centre

64. A coping programme moderately reduces depression and anxiety in carers of people with dementia

A coping programme moderately reduces depression and anxiety in carers of people with dementia NIHR DC | Signal - A coping programme moderately reduces depression and anxiety in carers of people with dementia Dissemination Centre Discover Portal NIHR DC Discover NIHR Signal A coping programme moderately reduces depression and anxiety in carers of people with dementia Published on 28 October 2015 This NIHR-funded trial found that a programme to support carers of people with dementia (...) was moderately effective in reducing carers’ depression and anxiety scores for up to two years. It was also cost-effective. The programme consisted of eight sessions delivered by psychology graduates, covering topics such as managing difficult behaviour, accessing support and planning for the future. One in three people over 65 develop dementia and family are often the primary caregivers. The findings of this trial support NICE recommendations that the psychological burden upon carers is assessed

2018 NIHR Dissemination Centre

65. Coordinating care for people with long term conditions and dementia: room for improvement

Coordinating care for people with long term conditions and dementia: room for improvement NIHR DC | Signal - Coordinating care for people with long term conditions and dementia: room for improvement Dissemination Centre Discover Portal NIHR DC Discover NIHR Signal Coordinating care for people with long term conditions and dementia: room for improvement Published on 26 May 2016 New evidence shows that almost one fifth of people with dementia also have other serious conditions such as stroke (...) , diabetes and visual impairment. Services are not currently designed to provide adequate integrated care for people with dementia plus other conditions. For instance, people with dementia are less likely to get diabetes checks or cataract surgery than those without dementia. Carers are not routinely contacted, and there is a lack of guidance for health professionals covering more than one condition. Implications for practice include incorporating the impact of a diagnosis of dementia on pre-existing

Full Text available with Trip Pro

2018 NIHR Dissemination Centre

66. A third of people with dementia have treatable vision problems

A third of people with dementia have treatable vision problems NIHR DC | Signal - A third of people with dementia have treatable vision problems Dissemination Centre Discover Portal NIHR DC Discover NIHR Signal A third of people with dementia have treatable vision problems Published on 27 September 2016 New data shows that around a third of people with dementia have serious vision problems, such as cataracts or short sightedness, more than the general population of that age. Levels are higher (...) still for people with dementia in care homes – about half have vision problems. Yet this study showed that many of the people with dementia and vision impairment had not received the right treatment. This often involves simple measures. For many, spectacles could have improved poor sight. A quarter had cataracts, which surgery could have corrected. Quality of life is known to improve if visual impairment is corrected. Failure to receive treatment may be due to lack of awareness amongst people

2018 NIHR Dissemination Centre

67. Diagnostic accuracy of Instrumental Activities of Daily Living for dementia in community-dwelling older adults

Diagnostic accuracy of Instrumental Activities of Daily Living for dementia in community-dwelling older adults 29528375 2018 03 12 1468-2834 2018 Mar 08 Age and ageing Age Ageing Diagnostic accuracy of Instrumental Activities of Daily Living for dementia in community-dwelling older adults. 10.1093/ageing/afy021 many people living with dementia remain underdiagnosed and unrecognised. Screening strategies are important for early detection. to examine whether the Lawton's Instrumental Activities (...) of Daily Living (IADL) scale, compared with other cognitive screening tools-the Mini-Mental State Examination (MMSE), and the Ascertain Dementia 8-item Informant Questionnaire (AD8)-can identify older (≥ 65 years) adults with dementia. population-based cross-sectional observational study. all 19 counties in Taiwan. community-dwelling older adults (n = 10,340; mean age 74.87 ± 6.03). all participants underwent a structured in-person interview. Dementia was identified using National Institute on Aging

Full Text available with Trip Pro

2018 EvidenceUpdates

68. A randomised controlled trial to evaluate the impact of a human rights based approach to dementia care in inpatient ward and care home settings.

A randomised controlled trial to evaluate the impact of a human rights based approach to dementia care in inpatient ward and care home settings. A randomised controlled trial to evaluate the impact of a human rights based approach to dementia care in inpatient ward and care home settings. Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from (...) the navigation or try a website search above to find the information you need. >> >> >> >> Issue {{metadata .Issue }} Toolkit 1)"> 0)"> {{metadata.Title}} {{metadata.Headline}} The findings of this study did not support the hypothesis that increasing staff knowledge and attitudes towards human rights improves the quality of life of people with dementia. {{author}} {{($index , , , , , , & . Peter Kinderman 1 , Sarah Butchard 2, * , Ashley J Bruen 1 , Abbie Wall 1 , Nia Goulden 3 , Zoe Hoare 3 , Carys Jones 4

2018 NIHR HTA programme

69. Withdrawal versus continuation of long-term antipsychotic drug use for behavioural and psychological symptoms in older people with dementia. (PubMed)

Withdrawal versus continuation of long-term antipsychotic drug use for behavioural and psychological symptoms in older people with dementia. BACKGROUND: Antipsychotic agents are often used to treat neuropsychiatric symptoms (NPS) in people with dementia although there is uncertainty about the effectiveness of their long-term use for this indication and concern that they may cause harm, including higher mortality. When behavioural strategies have failed and treatment with antipsychotic drugs (...) is instituted, regular attempts to withdraw them have been recommended in guidelines. Physicians, nurses and families of older people with dementia may be reluctant to stop antipsychotics, fearing deterioration of NPS.This is an update of a Cochrane Review published in 2013. OBJECTIVES: To evaluate whether withdrawal of antipsychotic agents is successful in older people with dementia and NPS in primary care or nursing home settings, to list the different strategies for withdrawal of antipsychotic agents

2018 Cochrane

70. Living condition, weight loss and cognitive decline among people with dementia (PubMed)

Living condition, weight loss and cognitive decline among people with dementia Living condition, weight loss and cognitive decline among people with dementia - Harsányiová - 2018 - Nursing Open - Wiley Online Library By continuing to browse this site, you agree to its use of cookies as described in our . Search term Search Search term Search The full text of this article hosted at iucr.org is unavailable due to technical difficulties. RESEARCH ARTICLE Open Access Living condition, weight loss (...) and cognitive decline among people with dementia Faculty of Health Care and Social Work, Trnava University, , Trnava, Slovakia Corresponding Author E-mail address: Faculty of Education, Department of Biology, Trnava University, , Trnava, Slovakia Institute of Zoology, Slovak Academy of Sciences, , Bratislava, Slovakia Correspondence Pavol Prokop, Faculty of Education, Department of Biology, Trnava University, Trnava, Slovakia. Email: Faculty of Health Care and Social Work, Trnava University, , Trnava

Full Text available with Trip Pro

2018 Nursing open

71. Astrocyte dysfunction following molybdenum-associated purine loading could initiate Parkinson’s disease with dementia (PubMed)

Astrocyte dysfunction following molybdenum-associated purine loading could initiate Parkinson’s disease with dementia PERSPECTIVE OPEN Astrocyte dysfunction following molybdenum-associated purineloadingcouldinitiateParkinson’sdiseasewithdementia Christopher A. Bourke 1 Sporadic or idiopathic Parkinson’s disease is a movement disorder with a worldwide distribution, a long pre-clinical latent period and a frequent association with dementia. The combination of molybdenum de?ciency and purine (...) ingestion could explain the movement disorder, the distribution, the latent period and the dementia association. Recent studies in sheep have shown that molybdenum de?ciency enables some dietary purines to accumulate in the central nervous system. This causes astrocyte dysfunction, altered neuromodulation and eventually irreversible central nervous system disease. Humans and sheep share the ability to salvage purines and this ability places humans at risk when they ingest xanthosine, inosine, adenosine

Full Text available with Trip Pro

2018 NPJ Parkinson's disease

72. Reminiscence therapy for dementia. (PubMed)

Reminiscence therapy for dementia. BACKGROUND: This updated Cochrane Review of reminiscence therapy (RT) for dementia was first published in 1998, and last updated in 2005. RT involves the discussion of memories and past experiences with other people using tangible prompts such as photographs or music to evoke memories and stimulate conversation. RT is implemented widely in a range of settings using a variety of formats. OBJECTIVES: To assess the effects of RT on people living with dementia (...) and their carers, taking into account differences in its implementation, including setting (care home, community) and modality (group, individual). SEARCH METHODS: We searched ALOIS (the Cochrane Dementia and Cognitive Improvement Group's Specialized Register) on 6 April 2017 using the search term 'reminiscence.' SELECTION CRITERIA: We included all randomised controlled trials of RT for dementia in which the duration of the intervention was at least four weeks (or six sessions) and that had a 'no treatment

Full Text available with Trip Pro

2018 Cochrane

73. Mini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a primary care setting. (PubMed)

Mini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a primary care setting. BACKGROUND: Alzheimer's disease and other forms of dementia are becoming increasingly common with the aging of most populations. The majority of individuals with dementia will first present for care and assessment in primary care settings. There is a need for brief dementia screening instruments that can accurately diagnose dementia in primary care settings. The Mini-Cog is a brief (...) , cognitive screening test that is frequently used to evaluate cognition in older adults in various settings. OBJECTIVES: To determine the diagnostic accuracy of the Mini-Cog for diagnosing Alzheimer's disease dementia and related dementias in a primary care setting. SEARCH METHODS: We searched the Cochrane Dementia and Cognitive Improvement Register of Diagnostic Test Accuracy Studies, MEDLINE, Embase and four other databases, initially to September 2012. Since then, four updates to the search were

2018 Cochrane

74. ACHIEVING A PEACEFUL DEATH: What We've Learned in 30 Years, Including Dementia

ACHIEVING A PEACEFUL DEATH: What We've Learned in 30 Years, Including Dementia ACHIEVING A PEACEFUL DEATH: What We've Learned in 30 Years, Including Dementia - Medicalvideos Breaking News Fetching data... ☰ Navigation ACHIEVING A PEACEFUL DEATH: What We've Learned in 30 Years, Including Dementia Jumat, 09 Februari 2018 Check out this on November 4, 2017 that celebrates the 30-year anniversary of the Hemlock Society of San Diego. Distinguished Guests include: Derek Humphry, Founder (...) of the Hemlock Society USA (1980), author of "Final Exit" Kathryn Tucker, J.D., Executive Director, End of Life Liberty Project Rob Jonquiére, M.D., Executive Director, World Federation of Right to Die Societies Topics will include: What to do About Alzheimer's Disease and Dementia The POLST and How to Use It Death in Switzerland: Pros and Cons The Final Exit Network: Who They Are and How They can Help You California's End of Life Option Act Do-It-Yourself Methods Do-Not-Resuscitate Orders (DNR) Further

2018 MedicalVideos

75. Diagnosis of dementia in the elderly with PTSD

Diagnosis of dementia in the elderly with PTSD Diagnosis of dementia in the elderly with PTSD We use cookies on this website. By using this site, you agree that we may store and access cookies on your device. Swedish Agency for Health Technology Assessment and Assessment of Social Services Diagnosis of dementia in the elderly with PTSD Share: Reading time less than 1 minute Some of the symptoms of posttraumatic stress disorder (PTSD) remind of the symptoms of early development of dementia (...) . This can make it difficult with an assessment tool to clearly see if a person diagnosed with PTSD has started to develop dementia. Question Is there scientific evidence for any assessment tool that can identify development of dementia in the elderly with PTSD? SBU Enquiry response consists of systematic literature searches to highlight studies that can address questions received by the SBU Enquiry Service from Swedish healthcare or social service providers. Relevant references are compiled by an SBU

2018 Swedish Council on Technology Assessement

76. Effects of Cognitive Training on Cognition and Quality of Life of Older Persons with Dementia

Effects of Cognitive Training on Cognition and Quality of Life of Older Persons with Dementia 29345724 2018 01 18 1532-5415 2018 Jan 18 Journal of the American Geriatrics Society J Am Geriatr Soc Effects of Cognitive Training on Cognition and Quality of Life of Older Persons with Dementia. 10.1111/jgs.15196 To evaluate the effect of cognitive training on cognition and health-related quality of life (HRQoL) in community-dwelling persons with dementia. Single-blind randomized controlled trial (...) with 3- and 9-month follow-up. Adult day care centers in Helsinki, Finland. Older individuals with mild to moderate dementia living at home and attending adult day care twice a week (N = 147; mean age 83, 72% female, 63% at mild stage of dementia). A systematic 12-week training program focused on subskills of executive function: attention, working memory, cognitive flexibility, and planning. The intervention group (n = 76) underwent cognitive training twice a week for 45 minutes, and the control

2018 EvidenceUpdates

77. What is desirable care in the opinion of formal and informal caregivers in nursing‐home care for patients with dementia? (PubMed)

What is desirable care in the opinion of formal and informal caregivers in nursing‐home care for patients with dementia? Nursing Open. 2018;5:139–148. | 139 wileyonlinelibrary.com/journal/nop2 1 | INTRODUCTION Nursing homes in the Netherlands provide psycho geriatric care to pa- tients with dementia and other disorders in the function of the brain. The care in the nursing homes is subsidized by the national govern- ment, with the patient making a financial contribution as well. There are two (...) kinds of nursing homes: small- scale nursing homes and large- scale nursing homes. The organization of care in small- scale nursing homes differs from the care in large- scale homes. In small- scale nurs- ing homes, the formal caregiver is responsible for a group of patients and their family representatives. In large- scale nursing homes a group of formal caregivers is responsible for all the patients and the care is delivered using a task- centered approach. In 2008, 36,934 patients with dementia

Full Text available with Trip Pro

2018 Nursing open

78. Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease. (PubMed)

Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease. BACKGROUND: Alzheimer's disease is characterized by amyloid-beta (Aβ) plaques and neurofibrillary tangles. The humanized monoclonal antibody solanezumab was designed to increase the clearance from the brain of soluble Aβ, peptides that may lead to toxic effects in the synapses and precede the deposition of fibrillary amyloid. METHODS: We conducted a double-blind, placebo-controlled, phase 3 trial involving patients with mild (...) dementia due to Alzheimer's disease, defined as a Mini-Mental State Examination (MMSE) score of 20 to 26 (on a scale from 0 to 30, with higher scores indicating better cognition) and with amyloid deposition shown by means of florbetapir positron-emission tomography or Aβ1-42 measurements in cerebrospinal fluid. Patients were randomly assigned to receive solanezumab at a dose of 400 mg or placebo intravenously every 4 weeks for 76 weeks. The primary outcome was the change from baseline to week 80

Full Text available with Trip Pro

2018 NEJM

79. Advancing Care for Family Caregivers of persons with dementia through caregiver and community partnerships (PubMed)

Advancing Care for Family Caregivers of persons with dementia through caregiver and community partnerships RESEARCH ARTICLE Open Access Advancing Care for Family Caregivers of persons with dementia through caregiver and community partnerships Carole L. White 1* , Kristen J. Overbaugh 1 , Carolyn E. Z. Pickering 1 , Bridgett Piernik-Yoder 2 , Debbie James 1 , Darpan I. Patel 1 , Frank Puga 1 , Lark Ford 1 and James Cleveland 1 Abstract Background: There are currently 15 million Americans who (...) provide over 80% of the care required by their family members with Alzheimer’s disease and other dementias. Yet care for caregivers continues to be fragmented and few evidence-based interventions have been translated into routine clinical care and therefore remain inaccessible to most family caregivers. To address this gap, the Caring for the Caregiver program is being developed at UT Health San Antonio, School of Nursing to improve support services and health outcomes for family caregivers. Our

Full Text available with Trip Pro

2018 Research involvement and engagement

80. Cannabinoids for Behavioural Symptoms in Adults with Dementia: A Review of Clinical Effectiveness and Guidelines

Cannabinoids for Behavioural Symptoms in Adults with Dementia: A Review of Clinical Effectiveness and Guidelines Cannabinoids for Behavioural Symptoms in Adults with Dementia: A Review of Clinical Effectiveness and Guidelines | CADTH.ca Find the information you need Cannabinoids for Behavioural Symptoms in Adults with Dementia: A Review of Clinical Effectiveness and Guidelines Cannabinoids for Behavioural Symptoms in Adults with Dementia: A Review of Clinical Effectiveness and Guidelines (...) Published on: January 5, 2018 Project Number: RC0952-000 Product Line: Research Type: Drug Report Type: Summary with Critical Appraisal Result type: Report Question What is the clinical effectiveness of cannabinoids for the treatment of behavioural symptoms in adults with dementia? What are the evidence-based guidelines regarding the use of cannabinoids for the treatment of behavioural symptoms in adults with dementia? Key Message A total of four publications met the inclusion criteria: two systematic

2018 Canadian Agency for Drugs and Technologies in Health - Rapid Review